Share on Pinterest A clinical trial shows that Zepbound and Mounjaro reduced obstructive sleep apnea symptoms in people with obesity. NurPhoto/Getty Images Around 70% of people who have obstructive ...

The American Academy of Sleep Medicine has indicated that an estimated 26 percent of adults between the ages of 30 and 70 years have sleep apnea. (Photo: Getty) You could say that it’s difficult to ...

🛍️ Amazon Big Spring Sale: 100+ editor-approved deals worth buying right now 🛍️ By Lauren Leffer Published Aug 23, 2024 11:31 AM EDT Add Popular Science (opens in a new tab) Adding us as a Preferred ...

Credit: Getty Images Obstructive sleep apnea may significantly increase the risk for coronary artery disease, atrial fibrillation, cerebrovascular accident, and congestive heart failure. Obstructive ...

Losing 5–10% of your body weight can significantly reduce the severity of sleep apnea symptoms and, in some cases, eliminate the condition altogether. Weight loss, through a combination of diet and ...

An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March 28, 2024. Patients, doctors and pharmacists across the US are struggling to get their ...

The American Medical Association reports that about 30 million people in the US live with sleep apnea, but only one-fifth of these cases are clinically diagnosed. That means that many people are ...

ORLANDO, Fla. — The diabetes and weight loss drug tirzepatide (Mounjaro for type 2 diabetes; Zepbound for obesity) was so effective at reducing sleep disruptions in patients with obesity and ...

Snoring is the 'hallmark of sleep apnea', a doctor says, but there are other signs and metrics to look for on your sleep ...

Background: The pathogenesis of daytime hypercapnia (PaCO 2 ≥ 45 mm Hg) may be directly linked to the existence of obstructive sleep apnea syndrome (OSAS) per se, although only some patients with OSAS ...